Michael Sebag, MD, PhD¹, Noopur S. Raje, MD², Nizar J. Bahlis, MD³, Caitlin Costello, MD⁴, Bhagirathbhai Dholaria, MBBS⁵, Melhem Solh, MD⁶, Moshe Y. Levy, MD^7,8, Michael H. Tomasson, MD⁹, Harman Dube, PhD^10*, Michael A. Damore, PhD^10*, Hoi Ken Lon, PhD^10*, Cynthia Basu, PhD^11*, Athanasia Skoura, PhD^12*, Edward Chan, MD^13*, Suzanne Trudel, MD¹⁴, Andrzej Jakubowiak¹⁵, Michael P. Chu, MD¹⁶, Cristina Gasparetto, MD¹⁷, Andrew P. Dalovisio, MD¹⁸ and Alexander Lesokhin, MD¹⁹

¹Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
²Massachusetts General Hospital Cancer Center, Boston, MA
³Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada
⁴UC San Diego Health, Moores Cancer Center, La Jolla, CA
⁵Vanderbilt University Medical Center, Nashville, TN
⁶BMT Group of Georgia, BMT Group of Georgia, Atlanta, GA
⁷Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX
⁸Baylor Scott & White Research Institute, Dallas, TX
⁹University of Iowa, Iowa City, IA
¹⁰Pfizer, San Diego, CA
¹¹Early Clinical Development, Pfizer, San Diego, CA
¹²Oncology Research and Development, Pfizer, Collegeville, PA
¹³Oncology Research and Development, Pfizer, San Francisco, CA
¹⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁵University of Chicago, Chicago, IL
¹⁶Cross Cancer Institute, Edmonton, AB, Canada
¹⁷Duke University Hospital, Durham, NC
¹⁸Department of Hematology and Oncology, Ochsner Health, Jefferson, LA
¹⁹Memorial Sloan Kettering Cancer Center, New York, NY

Philippe Moreau, MD, PhD^1*, Saad Z. Usmani, MD MBA FACP², Alfred L. Garfall^3*, Niels W.C.J. van de Donk⁴, Hareth Nahi^5*, Jesus San-Miguel⁶, Albert Oriol^7*, Ajay K. Nooka⁸, Thomas Martin, MD⁹, Laura Rosinol^10*, Ajai Chari, MD^11*, Lionel Karlin^12*, Lotfi Benboubker^13*, Maria-Victoria Mateos¹⁴, Nizar J. Bahlis, MD¹⁵, Rakesh Popat, MBBS, FRCPath, PhD^16*, Britta Besemer^17*, Joaquín Martínez-López^18*, Surbhi Sidana, MD¹⁹, Lixia Pei^20*, Danielle Trancucci^20*, Raluca I. Verona^21*, Suzette Girgis²¹, Yunsi Olyslager^22*, Mindy Jaffe^21*, Clarissa M. Uhlar^21*, Tara Stephenson^21*, Rian Van Rampelbergh^22*, Arnob Banerjee^21*, Jenna D. Goldberg^20*, Rachel Kobos²⁰ and Amrita Y. Krishnan, MD²³

¹Hematology Clinic, University Hospital Hôtel-Dieu, Nantes, France
²Levine Cancer Institute/Atrium Health, Charlotte, NC
³Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁴Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
⁵Karolinska University Hospital at Huddinge, Karolinska Institute, Stockholm, Sweden
⁶Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain
⁷Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain
⁸Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁹University of California San Francisco, San Francisco, CA
¹⁰Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
¹¹Mount Sinai School of Medicine, New York, NY
¹²Service d’Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
¹³Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France
¹⁴University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
¹⁵Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
¹⁶University College London Hospitals, NHS Foundation Trust, London, United Kingdom
¹⁷Department of Hematology, Oncology, and Immunology, University of Tuebingen, Tuebingen, Germany
¹⁸Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain
¹⁹Stanford University School of Medicine, Stanford, CA
²⁰Janssen Research & Development, Raritan, NJ
²¹Janssen Research & Development, Spring House, PA
²²Janssen Research & Development, Antwerp, Belgium
²³City of Hope Comprehensive Cancer Center, Duarte, CA

Natalie S. Callander, MD¹, Vincent Ribrag, MD², Paul G. Richardson, MD³, Ajay K. Nooka⁴, Kevin Song, MD, FRCPC⁵, Katarina Uttervall, MD, PhD^6*, Monique C. Minnema, MD⁷, Katja Weisel^8*, Hang Quach, FRACP, FRCPA⁹, Chang-Ki Min, M.D., Ph.D.^10*, Marc S. Ballas, MD, MPH^11*, Xiaofang Li^11*, Nirav Ratia^12*, Morrys Kaisermann, MD, PhD^11*, Beata Holkova, MD^11* and Suzanne Trudel, MD¹³

¹Carbone Cancer Center, University of Wisconsin, Madison, WI
²Institut Gustave Roussy, Villejuif, France
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Emory University, Winship Cancer Institute, Atlanta, GA
⁵Vancouver General Hospital, Vancouver, BC, Canada
⁶Karolinska University Hospital, Stockholm, Sweden
⁷University Medical Center Utrecht, Utrecht, Netherlands
⁸University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹University of Melbourne, St. Vincent’s Hospital Melbourne, Melbourne, VIC, Australia
¹⁰Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹¹GlaxoSmithKline, Upper Providence, PA
¹²GlaxoSmithKline, Brentford, Middlesex, United Kingdom
¹³Princess Margaret Cancer Centre, Toronto, ON, Canada

Dan T. Vogl^1*, Jonathan L. Kaufman, MD², Sarah A. Holstein, MD, PhD³, Shebli Atrash, MD⁴, Omar Nadeem, MD⁵, Murali Janakiram, MD, MS^6*, Kaveri Suryanarayan, MD^7*, Yuyin Liu^7*, Sabrina Collins^7*, Xavier Parot, MD^7* and Maria Chaudhry, MBBS⁸

¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Winship Cancer Institute of Emory University, Atlanta, GA
³Nebraska Medical Center, Omaha, NE
⁴Levine Cancer Institute, Charlotte, NC
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶University of Minnesota, Minneapolis, MN
⁷Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
⁸Ohio State University Comprehensive Cancer Center, Columbus, OH

David J. Chung, MD, PhD¹, Nina Shah, MD², Dina Stroopinsky^3*, Juan WU^4*, Lina Bisharat^5*, Natalie S. Callander, MD⁶, Brent R. Logan, PhD^7*, Kenneth C. Anderson, MD^8,9,10, Thinle Chodon, MD^11*, Meera Mohan, MD^12,13, Steven Devine, MD¹⁴, Yvonne A. Efebera, MD, MPH¹⁵, Nancy Geller, PhD^16*, Peiman Hematti, MD¹⁷, Leona A. Holmberg, MD, PhD¹⁸, Alan Howard, PhD^19*, Bryon Johnson, PhD²⁰, Hillard M Lazarus, MD²¹, Ehsan Malek, MD²², Philip L. McCarthy, MD²³, David H. McKenna, MD²⁴, Adam M. Mendizabal, MS²⁵, Nikhil C. Munshi, MD, PhD²⁶, Lynn O'Donnell, PhD^27*, Aaron P. Rapoport, MD²⁸, Ajay K. Nooka²⁹, Jane Reese^30*, Robert J. Soiffer, MD³¹, Lynne Uhl, MD³², Giulia Cheloni, PhD^3*, Dimitra Karagkouni, PhD^3*, Ioannis Vlachos, PhD^3*, James W. Young, MD³³, Jacalyn Rosenblatt, MD⁵, Edmund K. Waller, PhD, MD²⁹, Marcelo C Pasquini, MD, MS^34,35 and David Avigan, MD^5,36

¹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²University of California San Francisco, San Francisco, CA
³Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁴The Emmes Corporation, Rockville, MD
⁵Beth Israel Deaconess Medical Center, Boston, MA
⁶University of Wisconsin, Madison, WI
⁷Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
⁸Jerome Lipper Multiple Myeloma Center, LeBow Institute for Myeloma Therapeutics, Dana-farber/Boston Children's Cancer and Blood Disorders Ctr, Boston, MA
⁹Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
¹⁰The LeBow Institute for Myeloma Therapeutics, Dana-Farber Cancer Institute, Boston, MA
¹¹Roswell Park, Buffalo, NY
¹²Medical College of Wisconsin, Milwaukee, WI
¹³Clinical Cancer Center, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI
¹⁴National Marrow Donor Program, Minneapolis, MN
¹⁵Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
¹⁶National Institutes of Health, Bethesda, MD
¹⁷Division of Hematology/Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI
¹⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁹Center for International Blood and Marrow Transplant Research, Manager, Immunobiology Research, Minneapolis, MN
²⁰Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
²¹Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Cleveland Medical Center, Shaker Heights, OH
²²Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
²³Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
²⁴Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
²⁵The Emmes Company, Rockville, MD
²⁶Dana-Farber Cancer Institute, Harvard Medical School, Boston
²⁷Comprehensive Cancer Center, Ohio State University Medical Center - James Cancer Hospital, Columbus, OH
²⁸Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
²⁹Winship Cancer Institute, Emory University, Atlanta, GA
³⁰Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
³¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³²Department of Pathology, Beth Israel Deaconess Med. Ctr., Boston, MA
³³Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
³⁴CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
³⁵Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³⁶Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

Shaji K Kumar, MD¹, Anita D'Souza, MD, MS^2,3,4, Nina Shah, MD^5,6, Cesar Rodriguez⁷, Peter M. Voorhees, MD⁸, Orlando F. Bueno, MD, PhD⁹, Ben Buelow, MD¹⁰, Kevin J. Freise, PhD, MS⁹, Susan Yue, MD^9*, Rajvineeth Kumar Pothacamury, MD^11*, Akshanth R. Polepally, PhD^11* and Ravi Vij, MBBS¹²

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Division of Hematology Oncology, CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
⁴CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵University of California San Francisco, San Francisco, CA
⁶Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA
⁷Medical Oncology and Hematology, Wake Forest University School of Medicine, Winston-Salem, NC
⁸Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
⁹AbbVie, Inc., North Chicago, IL
¹⁰TeneoBio, Inc., Menlo Park, CA
¹¹AbbVie Inc., North Chicago, IL
¹²Washington University School of Medicine, Ballwin, MO